MX390246B - Composicion prebiotica sinergica. - Google Patents
Composicion prebiotica sinergica.Info
- Publication number
- MX390246B MX390246B MX2017003293A MX2017003293A MX390246B MX 390246 B MX390246 B MX 390246B MX 2017003293 A MX2017003293 A MX 2017003293A MX 2017003293 A MX2017003293 A MX 2017003293A MX 390246 B MX390246 B MX 390246B
- Authority
- MX
- Mexico
- Prior art keywords
- prebiotic
- synergical
- present
- prebiotic composition
- compositions
- Prior art date
Links
- 235000013406 prebiotics Nutrition 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 2
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 2
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 abstract 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 abstract 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940061720 alpha hydroxy acid Drugs 0.000 abstract 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 abstract 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 abstract 1
- 229960000511 lactulose Drugs 0.000 abstract 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000001630 malic acid Substances 0.000 abstract 1
- 235000011090 malic acid Nutrition 0.000 abstract 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Abstract
La presente invención se refiere a composiciones y formulaciones prebióticas que comprenden un a-hidroxiácido y sus sales, tales como ácido láctico, glicólico, cítrico, tartárico o málico y un agente prebiótico, tal como inulina, fructooligosacárido (FOS), lactulosa, galactooligosacárido (GOS), rafinosa, estaquiosa, isomaltooligosacárido, y xilooligosacárido. Las composiciones prebióticas de la presente invención proporcionan un efecto prebiótico sorprendentemente sinérgico y pueden administrarse de varias formas a un usuario, tales como por aplicación a un sustrato de limpieza prehumedecido o papel sanitario seco.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2014/058369 WO2016053308A1 (en) | 2014-09-30 | 2014-09-30 | Synergistic prebiotic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017003293A MX2017003293A (es) | 2017-06-21 |
| MX390246B true MX390246B (es) | 2025-03-20 |
Family
ID=55631163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017003293A MX390246B (es) | 2014-09-30 | 2014-09-30 | Composicion prebiotica sinergica. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10441603B2 (es) |
| EP (1) | EP3200766B1 (es) |
| KR (1) | KR20170065540A (es) |
| CN (1) | CN107072941B (es) |
| AU (1) | AU2014407509B2 (es) |
| BR (1) | BR112017004630B1 (es) |
| CO (1) | CO2017003280A2 (es) |
| MX (1) | MX390246B (es) |
| WO (1) | WO2016053308A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2636621C1 (ru) * | 2016-08-08 | 2017-11-24 | Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" | Препарат-пребиотик для овец |
| WO2021061789A1 (en) * | 2019-09-23 | 2021-04-01 | The Regents Of The University Of Michigan | Compositions and methods for increasing the efficacy of immunotherapies and vaccines |
| WO2022165030A1 (en) * | 2021-01-27 | 2022-08-04 | Prenexus Health, Inc. | Xylooligosaccharide as a multifunctional prebiotic |
| CN119326802B (zh) * | 2024-12-19 | 2025-05-30 | 江西益百润生物科技有限公司 | 联合益生菌和益生元的组合物及其制备方法和应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2738652C3 (de) | 1977-08-26 | 1981-02-19 | Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) | Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen |
| US6716435B1 (en) | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
| US7144173B2 (en) * | 1998-11-09 | 2006-12-05 | The Procter & Gamble Company | Cleaning composition, pad, wipe, implement, and system and method of use thereof |
| US20030185811A1 (en) | 2001-02-06 | 2003-10-02 | Steve Teasdale | Herbal extract and preparation thereof |
| EP1530479A2 (de) | 2002-08-16 | 2005-05-18 | Finzelberg GmbH & Co. KG | Arznei-, nahrungsergänzungsmittel und futtermittelzusatz |
| EP1471070A1 (en) | 2003-04-22 | 2004-10-27 | Royal Schouten Group N.V. | Method for recovering a secondary plant metabolite |
| WO2005021575A2 (en) | 2003-08-29 | 2005-03-10 | Gregor Reid | Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| US20050112239A1 (en) | 2003-11-20 | 2005-05-26 | Rudin Richard E. | Instant yogurt food product |
| US7332179B2 (en) | 2003-12-12 | 2008-02-19 | Kimberly-Clark Worldwide, Inc. | Tissue products comprising a cleansing composition |
| AU2005323502A1 (en) | 2004-04-20 | 2006-07-13 | The University Of Chicago | Therapeutic delivery system comprising a high molecular weight PEG-like compound |
| US8110215B2 (en) | 2004-04-30 | 2012-02-07 | Kimberly-Clark Worldwide, Inc. | Personal care products and methods for inhibiting the adherence of flora to skin |
| EP1600062A1 (en) * | 2004-05-25 | 2005-11-30 | Cognis IP Management GmbH | Oral and/or topical compositions comprising prebiotics and sterols |
| US7642395B2 (en) | 2004-12-28 | 2010-01-05 | Kimberly-Clark Worldwide, Inc. | Composition and wipe for reducing viscosity of viscoelastic bodily fluids |
| EP1736537A1 (en) | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Methods and means for protecting the skin against pathogenic microorganisms |
| JP2009506056A (ja) | 2005-08-22 | 2009-02-12 | クイック−メッド テクノロジーズ、インク． | 基質の表面に抗菌カチオン性多価電解質を付着する方法 |
| US8444811B2 (en) * | 2005-12-15 | 2013-05-21 | Kimberly-Clark Worldwide, Inc. | Process for increasing the basis weight of sheet materials |
| CA2649896A1 (en) | 2006-04-21 | 2007-11-01 | Cadbury Adams Usa Llc | Coating compositions, confectionery and chewing gum compositions and methods |
| GB0724550D0 (en) | 2007-12-18 | 2008-01-30 | Univ Hull | Formulations |
| IT1392672B1 (it) * | 2009-01-12 | 2012-03-16 | Wyeth Consumer Healthcare S P A | Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina |
| WO2010123419A1 (en) * | 2009-04-20 | 2010-10-28 | Sca Hygiene Products Ab | Packaged wipe or hygiene tissue |
| WO2011053854A1 (en) | 2009-10-30 | 2011-05-05 | Biogenic Innovations, Llc | Use of methylsulfonylmethane (msm) to modulate microbial activity |
| BR112012011294B1 (pt) | 2009-11-12 | 2018-03-20 | Nestec S.A. | Composição nutricional para administração a um indivíduo |
| US8703716B2 (en) | 2010-03-12 | 2014-04-22 | Dsm Ip Assets B.V. | Maternal sialic acid supplementation |
| US20120035277A1 (en) | 2010-08-04 | 2012-02-09 | Hero Nutritionals, LLC | Liquid-filled chewable supplement |
| WO2012031186A1 (en) | 2010-09-03 | 2012-03-08 | Wisconsin Pharmacal Company, Llc. | Prebiotic suppositories |
| US8552251B2 (en) | 2010-10-08 | 2013-10-08 | Kimberly-Clark Worldwide, Inc. | Article with health-benefit agent delivery system |
| US9259019B2 (en) | 2010-11-11 | 2016-02-16 | Mars, Incorporated | Bifidobacteriumstrain |
| US8916012B2 (en) | 2010-12-28 | 2014-12-23 | Kimberly-Clark Worldwide, Inc. | Method of making substrates comprising frothed benefit agents |
| US8506978B2 (en) | 2010-12-28 | 2013-08-13 | Kimberly-Clark Worldwide, Inc. | Bacteriostatic tissue product |
| CN103687604A (zh) | 2011-03-01 | 2014-03-26 | 群体创新有限责任公司 | 用于治疗与致病生物膜相关之病症的材料和方法 |
| GB2495491A (en) | 2011-05-23 | 2013-04-17 | Bio4 Ltd | Pre-biotic skin wipe |
| CN102370598A (zh) * | 2011-09-30 | 2012-03-14 | 天津市中科健新材料技术有限公司 | 一种用于湿巾的益生元香体整理液 |
| US20150020946A1 (en) * | 2012-02-29 | 2015-01-22 | Bridgestone Corporation | Tire |
| JP6010310B2 (ja) * | 2012-03-05 | 2016-10-19 | Ｋｙｂ株式会社 | ロータリダンパ |
| EP2656862A1 (en) | 2012-04-24 | 2013-10-30 | The Procter & Gamble Company | Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate |
| US9243367B2 (en) | 2012-10-05 | 2016-01-26 | Kimberly-Clark Worldwide, Inc. | Soft creped tissue |
| CN102871921A (zh) | 2012-10-15 | 2013-01-16 | 金红叶纸业集团有限公司 | 洗手剂组合物 |
| CN103768651A (zh) * | 2012-10-17 | 2014-05-07 | 天津市中科健新材料技术有限公司 | 一种应用于婴儿纸尿裤的益生元粉体 |
| CN103110665B (zh) * | 2013-01-24 | 2015-12-02 | 量子高科(中国)生物股份有限公司 | 一种维护生殖道微生态屏障的组合物及其应用 |
| WO2015031105A1 (en) | 2013-08-28 | 2015-03-05 | The Procter & Gamble Company | Substrate comprising oligogalacturonides and disposable absorbent article comprising the substrate |
| US20150209468A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Hygiene article containing microorganism |
| US9539344B2 (en) | 2014-09-30 | 2017-01-10 | Kimberly-Clark Worldwide, Inc. | Creped prebiotic tissue |
-
2014
- 2014-09-30 US US15/512,951 patent/US10441603B2/en active Active
- 2014-09-30 CN CN201480081930.2A patent/CN107072941B/zh active Active
- 2014-09-30 WO PCT/US2014/058369 patent/WO2016053308A1/en not_active Ceased
- 2014-09-30 EP EP14903199.9A patent/EP3200766B1/en active Active
- 2014-09-30 MX MX2017003293A patent/MX390246B/es unknown
- 2014-09-30 AU AU2014407509A patent/AU2014407509B2/en active Active
- 2014-09-30 BR BR112017004630-0A patent/BR112017004630B1/pt active IP Right Grant
- 2014-09-30 KR KR1020177009906A patent/KR20170065540A/ko not_active Ceased
-
2017
- 2017-04-04 CO CONC2017/0003280A patent/CO2017003280A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20170258823A1 (en) | 2017-09-14 |
| EP3200766B1 (en) | 2019-07-03 |
| WO2016053308A1 (en) | 2016-04-07 |
| BR112017004630A2 (pt) | 2018-01-30 |
| CO2017003280A2 (es) | 2017-07-11 |
| AU2014407509B2 (en) | 2020-09-03 |
| CN107072941A (zh) | 2017-08-18 |
| BR112017004630B1 (pt) | 2023-04-11 |
| US10441603B2 (en) | 2019-10-15 |
| CN107072941B (zh) | 2020-10-13 |
| AU2014407509A1 (en) | 2017-04-13 |
| MX2017003293A (es) | 2017-06-21 |
| KR20170065540A (ko) | 2017-06-13 |
| EP3200766A4 (en) | 2018-06-06 |
| EP3200766A1 (en) | 2017-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017019411A2 (pt) | método para produção e uso de composição de detergente em forma de um tablete efervescente | |
| PH12017501079A1 (en) | 1,3-thiazol-2-yl substituted benzamides | |
| MX2016006060A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. | |
| AR097901A1 (es) | Agente beneficioso con partículas de administración | |
| MX2018007300A (es) | Composicion para la limpieza del cabello. | |
| MX2016006221A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. | |
| MX2016006220A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea. | |
| TN2015000371A1 (en) | Substituted imidazopyridazines | |
| PH12016501807A1 (en) | Novel compounds | |
| MX339413B (es) | Composiciones liquidas de limpieza y desinfeccion. | |
| MX378653B (es) | Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina. | |
| CO2017003280A2 (es) | Composición prebiótica sinérgica que comprende un agente prebiótico y un alfa-hidroxiácido, y toallita húmeda prebiótica que comprende una composición prebiótica líquida | |
| PL3046948T3 (pl) | Modyfikowane kwasy poliasparaginowe, ich wytwarzanie i ich zastosowanie jako dyspergatorów i środków zapobiegających powstawaniu osadów w kompozycjach środków do prania, zmywania i czyszczenia oraz w uzdatnianiu wody | |
| MX389674B (es) | Composiciones que comprenden tensioactivos y metodos de uso de las composiciones. | |
| MX2015008704A (es) | Limpiador de horno de dosis unitaria de tableta solida. | |
| MY185456A (en) | Skin cleanser composition | |
| PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
| PH12017500320B1 (en) | Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis | |
| BR112015004813A8 (pt) | composição de sabão, método de desinfecção de uma superfície e utilizações de uma composição | |
| PH12016501814A1 (en) | Inhibitors of the wnt signalling pathways | |
| CL2018002897A1 (es) | Sistemas de formulación para glicolípidos antimicrobianos. | |
| PE20170510A1 (es) | Composicion prebiotica sinergica | |
| MX2017006914A (es) | Barras de limpieza con taurina. | |
| MX2015007158A (es) | Antitranspirante/desodorante. | |
| Ramos et al. | Evaluation of the Effectiveness of Dental Whitening Strips |